What Biotech Growth Reveals About the Limits of Traditional Technology Leadership

I was in the middle of a conversation recently when something clicked for me. It was one of those moments where you realize you’ve been seeing the same pattern play out for years, but you hadn’t quite said it out loud yet.

We were talking about leadership. Not the kind you read about in a textbook or hear about in a keynote, but the kind that actually determines whether a company moves forward or stalls out. And more specifically, we were talking about what happens when companies grow.

Not slow, predictable growth. I mean real growth. The kind that changes everything underneath your feet.

That’s when it hit me. A lot of the leadership models we still rely on were built for environments that don’t look anything like modern biotech.

And when biotech companies start to scale, those models don’t just bend. They break.

When Strategy Is Handed to You

Earlier in my career, I spent a lot of time working with larger organizations. Big companies with established structures, defined processes, and layers of leadership that had been in place for years.

In those environments, strategy is usually already decided.

It comes from the top. It’s communicated clearly. It gets broken down into initiatives, roadmaps, and deliverables. And then people are hired to execute against it.

There is nothing inherently wrong with that model. In fact, in a stable environment, it works really well.

You know what you’re building. You know where you’re going. You know what success looks like.

Your job as a leader in that kind of environment is to take that strategy and execute it effectively. You are managing within a system that already exists.

There is very little ambiguity.

And for a lot of people, that’s comfortable. It’s predictable. It’s structured. It makes sense.

But that’s not the environment most biotech companies are operating in.

When You Are the Strategy

When you move into a smaller, high growth biotech company, everything changes.

The first thing that disappears is that sense of certainty.

There isn’t always a fully formed strategy waiting for you. There might be a vision. There might be a direction. But the details are often incomplete, evolving, or dependent on variables that are still being figured out.

In that environment, you are not just executing the strategy.

You are the strategy.

That’s a completely different expectation, and it’s where a lot of traditional leadership approaches start to fall apart.

I’ve had candidates come out of large organizations who are incredibly qualified on paper. They’ve worked at great companies. They’ve managed big teams. They’ve delivered results.

But when you put them into a smaller biotech environment, they struggle.

Not because they aren’t smart. Not because they don’t work hard.

They struggle because they are waiting for the strategy to be handed to them.

And it never comes.

The Weight of Every Decision

One of the biggest differences between large organizations and smaller biotech companies is the impact of individual decisions.

In a large company, each person is a smaller cog in a much bigger machine.

If something slips, there are usually buffers in place. Other teams can absorb the impact. The organization can course correct without everything falling apart.

There is margin for error.

In a smaller company, that margin disappears.

Every decision matters. Every hire matters. Every misstep shows up somewhere, whether it’s in the P&L, the timeline, or the overall trajectory of the business.

You can feel it.

I’ve seen situations where a single decision made by one person changed the direction of an entire company. Not in theory. In reality.

That kind of environment requires a different kind of leader.

You can’t just focus on your lane and assume everything else will sort itself out. You have to understand how your decisions connect to everything around you.

You have to think beyond your function.

You have to operate like the business is yours.

The Illusion of Control

Traditional leadership models often rely on a certain level of control.

Clear hierarchies. Defined roles. Structured communication. Predictable workflows.

Those things create efficiency in stable environments.

But in biotech, especially during periods of rapid growth, control is often an illusion.

Things are changing too quickly.

Priorities shift. Data evolves. Funding changes the pace. New information forces new decisions.

If you try to lead in that environment the same way you would in a stable enterprise setting, you end up slowing things down.

You create friction where there needs to be movement.

The leaders who succeed are the ones who can operate without needing everything to be fully defined.

They are comfortable in ambiguity.

Not because they like chaos, but because they know how to turn ambiguity into direction.

Adapting in Real Time

One of the things I listen for when I’m talking to candidates is how they handle change.

Not the kind of change where you have six months to plan and a full team to support the transition.

I’m talking about real time change.

The kind where you get new information and have to adjust immediately.

The kind where the path forward is not obvious.

Some people need structure before they can move. They want everything mapped out. They want clarity before they act.

Others are different.

They can take incomplete information, pull the right pieces together, and move forward with confidence. They can adjust as they go. They can make decisions without perfect data.

Those are the people who tend to do well in biotech environments.

Because that’s what the job actually requires.

Aligning Across the Business

Another place where traditional leadership models start to show their limits is in cross functional alignment.

In a large company, alignment is often built into the structure. Teams are defined. Processes are established. Communication flows through formal channels.

In a smaller biotech company, those structures are still being built.

Which means alignment doesn’t happen automatically.

It has to be created.

That requires leaders who can connect different parts of the organization, even when those parts are still figuring themselves out.

You have to be able to sit with someone in another function, understand their priorities, and find a way to move forward together.

You can’t just operate within your own silo.

And you definitely can’t rely on a top down directive to solve every problem.

The Difference Between Managing and Leading

This is where I see a lot of confusion.

People talk about leadership as if it’s one thing. It’s not.

There’s a difference between managing and leading, especially in high growth environments.

Managing is about maintaining systems. Keeping things on track. Making sure processes are followed.

Leading, in this context, is about creating direction when it doesn’t exist yet.

It’s about making decisions that shape the business, not just support it.

It’s about taking ownership beyond your job description.

In biotech, you need more of the second than the first.

Hiring for What Actually Matters

This is where my world comes into play.

When companies are hiring technology leaders, especially in biotech, they often start with the same checklist.

Years of experience. Specific technologies. Previous companies. Titles.

Those things matter. They are the baseline.

But they don’t tell you whether someone can actually operate in a high growth, ambiguous environment.

They don’t tell you whether someone can adapt, execute, and align across functions.

They don’t tell you whether someone can think like an owner.

That’s the part that takes time to figure out.

It takes conversations. It takes understanding what drives someone. It takes digging into how they’ve handled situations in the past.

I always tell people, I’m not trying to force a fit.

If it’s not there, it’s not there.

Because in an environment like this, forcing it doesn’t just create a bad hire.

It creates a problem that shows up across the business.

Why This Matters More Now

Biotech isn’t slowing down.

If anything, the pace is increasing. New technologies. New therapies. New ways of thinking about how companies are built and scaled.

That’s a good thing.

But it also means the gap between traditional leadership models and what’s actually needed is getting wider.

Companies that recognize that early have an advantage.

They hire differently. They build differently. They operate differently.

They don’t just look for people who can execute a predefined plan.

They look for people who can help create the plan.

The Leaders Who Make the Difference

At the end of the day, the leaders who stand out in biotech are not the ones who rely on structure to do their jobs.

They are the ones who can create structure where none exists.

They don’t wait for clarity. They build it.

They don’t stay in their lane. They connect the lanes.

They don’t treat their role as a function. They treat it as part of a larger system that they are responsible for moving forward.

And most importantly, they understand that in a high growth environment, leadership is not about maintaining the status quo.

It’s about shaping what comes next.

The Takeaway

If there’s one thing I’ve learned from watching companies grow, it’s this.

The environment determines the kind of leadership that works.

What works in a stable, enterprise setting does not automatically translate to a high growth biotech company.

And assuming that it does is where a lot of mistakes get made.

If you are building a team, you have to be clear about the environment you are operating in.

If you are stepping into a leadership role, you have to be honest about whether your approach fits that environment.

Because in biotech, especially when things are moving fast, the difference between the right leader and the wrong one is not subtle.

You see it in the decisions. You see it in the alignment. You see it in the outcomes.

And by the time it shows up, it’s usually already made an impact.

That’s why getting it right from the start matters.

And that’s why the limits of traditional leadership are not just an interesting idea.

They’re something you feel in real time as companies grow.

 

About The Author:

Steven Swan is a seasoned recruiter who has spent decades working at the intersection of technology and business, with a particular focus on helping companies find leaders who can actually move the needle. His approach goes far beyond matching resumes to job descriptions. He focuses on understanding what drives both the candidate and the organization, ensuring alignment that holds up over time, not just on day one. Known for his direct, experience-driven perspective, Steven brings a practical lens to leadership, hiring, and growth, shaped by years of seeing what works, what fails, and why the difference matters.

Are you looking for top IT talent in the pharmaceutical or biotech industry?

Contact us to discuss how we can bring top-tier IT talent to your organization. The Swan Group are executive leaders with extensive IT recruiting expertise in the biotech and pharmaceutical space. Our goal is to ensure that each professional we place and each client we work with achieves a competitive advantage based upon our services.

Are you a professional looking for a new opportunity?

Contact us to discuss your career options or browse our opportunities. As a small boutique firm, we are in the business of building careers, not just filling positions.

ABOUT THE SWAN GROUP

Our goal is to ensure that each professional we place and each client we work with achieves a competitive advantage based upon our services. Our specialty is high-level INFORMATION TECHNOLOGY placement within the Pharmaceutical, Bio-Pharmaceutical, and Consumer Products industries. Thoughts, comments, or would like to discuss further, please contact us.